Sign in

CIK 0001710072 · Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821725586
Phone
720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. 4 Option exercise General Counsel acquired 5,400 shares (option exercise)
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 8-K Event Regulation FD disclosure
  9. 4 Option exercise General Counsel acquired 5,400 shares (option exercise)
  10. 4 Option exercise Chief Scientific Officer acquired 172,585 shares (option exercise)
  11. 4 Open-market sale Chief Scientific Officer sold 479 shares at an average $19.11 ($9,155)
  12. 4 Open-market sale Chief Scientific Officer sold 69,740 shares at an average $19.91 ($1,388,788)
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 4 Open-market sale Chief Scientific Officer sold 29,451 shares at an average $19.82 ($583,823)
  16. 4 Open-market sale Chief Scientific Officer sold 44,172 shares at an average $17.88 ($789,909)
  17. 8-K Event Regulation FD disclosure
  18. 4 Open-market sale Chief Scientific Officer sold 7,182 shares at an average $18.17 ($130,483)
  19. 4 Open-market sale Chief Scientific Officer sold 1,270 shares at $18.02 ($22,885)
  20. 4 Open-market sale Chief Scientific Officer sold 21,028 shares at an average $18.39 ($386,743)

Page 18 of 22 · 423 filings